LXRXLEXICON PHARMACEUTICALS, INC.

Nasdaq lexpharma.com


$ 1.84 $ -0.05 (-2.65 %)    

Friday, 10-May-2024 11:15:28 EDT
QQQ $ 441.42 $ -1.50 (-0.34 %)
DIA $ 394.75 $ -0.56 (-0.14 %)
SPY $ 520.24 $ -1.28 (-0.25 %)
TLT $ 90.09 $ -0.22 (-0.24 %)
GLD $ 218.68 $ -1.10 (-0.5 %)
$ 1.89
$ 1.89
$ 1.83 x 300
$ 1.84 x 600
$ 1.83 - $ 1.89
$ 0.92 - $ 3.73
1,629,670
na
465.39M
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-03-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-27-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-30-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-06-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-lexicon-pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

 lexicon-pharmaceuticals-q1-2024-gaap-eps-020-inline-sales-1130m-miss-1401m-estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. ...

 leerink-partners-initiates-coverage-on-lexicon-pharmaceuticals-with-outperform-rating-announces-price-target-of-5

Leerink Partners initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Outperform rating and announces Price Tar...

 needham-reiterates-hold-on-lexicon-pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

 needham-reiterates-hold-on-lexicon-pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

 why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

 cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

 lexicon-pharmaceuticals-announces-clinical-data-on-the-impact-of-sotagliflozin-on-stroke-and-heart-attack-risk-among-four-lexicon-sponsored-presentations-at-the-american-college-of-cardiology-73rd-annual-scientific-session--expo

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor...

 lexicon-pharmaceuticals-inc-announces-new-post-hoc-analysis-of-intandem3-study-demonstrates-improvements-in-glycemic-control-with-sotagliflozin-treatment-in-patients-with-type-1-diabetes-and-chronic-kidney-disease

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that a post hoc analysis of clinical data from its inTandem3 Phase ...

 acadia-pharmaceuticals-ocular-therapeutix-asana-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

 dow-turns-higher-gds-holdings-shares-climb

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08%...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 crude-oil-edges-higher-lexicon-pharmaceuticals-shares-jump

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded dow...

 lexicon-pharmaceuticals-q4-eps-020-beats-022-estimate-cash-position-170m

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate ...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION